<DOC>
	<DOCNO>NCT01033630</DOCNO>
	<brief_summary>Atherosclerosis ( particular stroke heart attack ) important health issue modernize society high blood pressure important predisposing factor . Hypertensive subject chronic disease diabetes mellitus impaired renal function particularly vulnerable atherosclerotic complication spite standard antihypertensive therapy . Danshen Gegen commonly use Chinese materia medica treatment cardiac symptom atherosclerosis-related disorder . The objective study test Danshen Gegen cardiovascular-protective adjunctive regimen prevent high-risk hypertensive cohort primary atherosclerosis .</brief_summary>
	<brief_title>Cardiovascular-Protective Effects Herbal Medicine Danshen-Gegen</brief_title>
	<detailed_description>Danshen Gegen ( D &amp; G ) two traditional herbal medicine use cardiac symptom ancient Chinese medicinal literature . Recent study suggest therapeutic effect blood pressure lipid-lowering , anti-oxidation , microcirculation-promoting , foam cells-modulation beneficial effect atherogenic process coronary patient . To evaluate potential D &amp; G primary atherosclerosis prevention high risk hypertension . Patients high risk hypertension associate leave ventricular hypertrophy , diabetes mellitus renal insufficiency randomize receive D &amp; G herbal capsule ( 2gm/day ) , ( 1gm/day ) identical placebo capsule double-blind parallel fashion 12 month top anti-hypertensive treatment . Flow-mediated dilation ( endothelium-dependent dilation , FMD ) nitroglycerin-induced dilation ( endothelium-independent dilation , NTG ) brachial artery , carotid intima-media thickness ( surrogate atherosclerosis marker , IMT ) measure high resolution B-mode ultrasound .</detailed_description>
	<criteria>Highrisk hypertension : Asymptomatic hypertensive ( pretreatment BP &gt; 160/95mmHg ) subject , currently blood pressure control ( BP &lt; 140/90mmHg ) , Aged 3570 year With either ( ) leave ventricular hypertrophy ECG echocardiographic criterion , ( ii ) diabetes mellitus , ( iii ) mild renal impairment ( plasma creatinine 120250Âµmol/l ) Known intolerance D &amp; G due adverse effect , patient bleed , disorder longterm anticoagulation .</criteria>
	<gender>All</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>January 2006</verification_date>
</DOC>